Collegium Pharmaceutical, Inc. (COLL) financial statements (2022 and earlier)

Company profile

Business Address 100 TECHNOLOGY CENTER DRIVE
STOUGHTON, MA 02072
State of Incorp. VA
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments186,426174,116170,019146,633118,697153,22595,697
Cash and cash equivalents186,426174,116170,019146,633118,697153,22595,697
Receivables105,84483,32072,95377,9469,9692,129 
Inventory, net of allowances, customer advances and progress billings17,39415,6149,6437,8171,8131,316 
Inventory17,39415,6149,6437,8171,8131,316 
Prepaid expense3,6023,2801,2223,0351,434604628
Deferred costs      353
Other current assets27601411,008456304205
Other undisclosed current assets2,2501,4981,7421,0731,115997 
Total current assets:315,543277,888255,720237,512133,484158,57596,883
Noncurrent Assets
Operating lease, right-of-use asset7,6448,3919,047
Property, plant and equipment19,49118,98811,8549,2741,8261,038738
Intangible assets, net (including goodwill), including:268,723335,90429,50344,255 2,103 
Intangible assets, net (excluding goodwill)268,723335,904     
Other undisclosed intangible assets, net (including goodwill)  29,50344,255 2,103 
Restricted cash and investments2,5472,547  979797
Deferred income tax assets78,042  
Other noncurrent assets87123178204161204 
Total noncurrent assets:376,534365,95350,58253,7332,0843,442835
TOTAL ASSETS:692,077643,841306,302291,245135,568162,01797,718
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities33,40334,67239,72742,70114,22517,9855,765
Accounts payable4,18910,0166,24712,1505,6849,1063,537
Accrued liabilities29,21424,65633,48030,5518,5418,8792,228
Debt48,35347,4954,4891,642 2,6672,667
Estimated litigation liability2,750      
Other undisclosed current liabilities195,060157,284157,549144,78317,2634,944 
Total current liabilities:279,566239,451201,765189,12631,48825,5968,432
Noncurrent Liabilities
Long-term debt and lease obligation209,583218,35917,1059,858 1,4794,146
Long-term debt, excluding current maturities201,632209,5947,6679,858 1,4794,146
Operating lease, liability7,9518,7659,438
Liabilities, other than long-term debt   676 3468
Deferred revenue and credits 3468
Other liabilities   676   
Other undisclosed noncurrent liabilities(7,951)(8,765)     
Total noncurrent liabilities:209,583218,35917,10510,534 1,5134,214
Total liabilities:489,149457,810218,870199,66031,48827,10912,646
Stockholders' equity
Stockholders' equity attributable to parent, including:202,928186,03187,43291,585104,080134,90885,072
Common stock36353433332921
Treasury stock, value(42,861)      
Additional paid in capital502,095519,143447,297428,729402,096358,063214,062
Accumulated deficit(256,342)(333,147)(359,899)(337,177)(298,049)(223,184)(129,008)
Other undisclosed stockholders' equity attributable to parent      (3)
Total stockholders' equity:202,928186,03187,43291,585104,080134,90885,072
TOTAL LIABILITIES AND EQUITY:692,077643,841306,302291,245135,568162,01797,718

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues276,868310,016296,701280,41328,4761,711 
Revenue, net28,4761,711 
Cost of revenue
(Cost of Goods and Services Sold)
(126,251)(130,180)(193,660)(165,677)(2,595)(213) 
Gross profit:150,617179,836103,041114,73625,8811,498 
Operating expenses(132,989)(123,604)(126,789)(135,421)(101,328)(95,793)(26,907)
Other undisclosed operating income     213 
Operating income (loss):17,62856,232(23,748)(20,685)(75,447)(94,082)(26,907)
Nonoperating income (expense)122321,9351,687582(94)(348)
Investment income, nonoperating122321,9351,687   
Other nonoperating income (expense)    582(94)(348)
Interest and debt expense(21,014)(28,882)(909)(20,130) (94)91
Income (loss) from continuing operations before income taxes:(3,374)27,582(22,722)(39,128)(74,865)(94,270)(27,164)
Income tax expense (benefit)74,891(830)     
Net income (loss):71,51726,752(22,722)(39,128)(74,865)(94,270)(27,164)
Other undisclosed net income (loss) attributable to parent     94(91)
Net income (loss) available to common stockholders, basic:71,51726,752(22,722)(39,128)(74,865)(94,176)(27,255)
Interest on convertible debt4,675      
Net income (loss) available to common stockholders, diluted:76,19226,752(22,722)(39,128)(74,865)(94,176)(27,255)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):71,51726,752(22,722)(39,128)(74,865)(94,270)(27,164)
Comprehensive income (loss), net of tax, attributable to parent:71,51726,752(22,722)(39,128)(74,865)(94,270)(27,164)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: